Breaking News Instant updates and real-time market news.

VNET

21Vianet

$37.43 /

-1.305 (-3.37%)

06:43
03/03/21
03/03
06:43
03/03/21
06:43

21Vianet price target raised to $47 from $33 at Citi

Citi analyst Arthur Lai raised the firm's price target on 21Vianet Group to $47 from $33 and keeps a Buy rating on the shares ahead of the company's Q4 results. The 2021 capacity expansion target of 25,000 appears on track as 20,000 have already been granted power and power quotas, Lai tells investors in a research note.

  • 23

    Mar

  • 05

    Mar

  • 26

    Aug

VNET 21Vianet
$37.43 /

-1.305 (-3.37%)

11/04/20 Daiwa
21Vianet initiated with a Buy at Daiwa
09/28/20 BofA
21Vianet initiated with a Buy at BofA
09/28/20 BofA
21Vianet initiated with a Buy at BofA
07/14/20 UBS
21Vianet initiated with a Buy at UBS

TODAY'S FREE FLY STORIES

Hot Stocks
U.S. safety agency tells consumers to stop using new Peloton treadmill » 14:19
04/17/21
04/17
14:19
04/17/21
14:19
PTON

Peloton

$116.17 /

-3.77 (-3.14%)

The U.S. Consumer Product…

The U.S. Consumer Product Safety Commission issued a bulletin today about the "danger of popular Peloton Tread+ exercise machine after multiple incidents of small children and a pet being injured beneath the machines. The Commission has found that the public health and safety requires this notice to warn the public quickly of the hazard." The warning comes less than a month after Peloton itself released news of a child's death by a Peloton Tread+. The agency is continuing to investigate all known incidents of injury or death related to the Peloton Tread+. To date, CPSC is aware of 39 incidents including one death. CPSC staff believes the Peloton Tread+ "poses serious risks to children for abrasions, fractures, and death." It added, "In light of multiple reports of children becoming entrapped, pinned, and pulled under the rear roller of the product, CPSC urges consumers with children at home to stop using the product immediately." Reference Link

ShowHide Related Items >><<
PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

04/07/21 KeyBanc
Peloton Bike OTD times improving further, says KeyBanc
04/06/21 Credit Suisse
Peloton initiated with an Outperform at Credit Suisse
04/05/21 Evercore ISI
Peloton assumed at In Line from Outperform at Evercore ISI
03/31/21 Wolfe Research
Peloton initiated with a Peer Perform at Wolfe Research
PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

Periodicals
Coinbase 'the best way' to play bitcoin boom, Barron's says » 11:11
04/17/21
04/17
11:11
04/17/21
11:11
COIN

Coinbase

$341.27 /

+15.78 (+4.85%)

, BITCOIN

Bitcoin

/

+

Coinbase Global issued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIN Coinbase
$341.27 /

+15.78 (+4.85%)

BITCOIN Bitcoin
/

+

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

04/15/21 Loop Capital
Loop Capital starts Coinbase at Buy, sees 'lots of runway before takeoff'
04/15/21 Loop Capital
Coinbase initiated with a Buy at Loop Capital
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 DA Davidson
Coinbase price target raised to $650 from $440 at DA Davidson
BITCOIN Bitcoin
/

+

04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
COIN Coinbase
$341.27 /

+15.78 (+4.85%)

  • 14
    Apr
COIN Coinbase
$341.27 /

+15.78 (+4.85%)

BITCOIN Bitcoin
/

+

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

BITCOIN Bitcoin
/

+

Periodicals
O'Reilly Automotive stock should be a winner, Barron's says » 11:07
04/17/21
04/17
11:07
04/17/21
11:07
ORLY

O'Reilly Automotive

$530.48 /

+8.3 (+1.59%)

With the U.S. tiptoeing…

With the U.S. tiptoeing toward the end of the lockdowns, people will be driving more than they have in the past year, for work and for play, and O'Reilly Automotive stock should be one winner, Teresa Rivas writes in this week's edition of Barron's. The company has used the downtime caused by the pandemic to improve its business and gain market share, while expanding its bricks-and-mortar footprint, the author notes, adding that work should pay off in the months ahead as life continues to return to something like normal. Reference Link

ShowHide Related Items >><<
ORLY O'Reilly Automotive
$530.48 /

+8.3 (+1.59%)

ORLY O'Reilly Automotive
$530.48 /

+8.3 (+1.59%)

03/29/21 Wells Fargo
O'Reilly Automotive price target raised to $575 from $535 at Wells Fargo
03/26/21 Stephens
O'Reilly Automotive price target raised to $575, named Best Idea at Stephens
03/17/21 Wells Fargo
O'Reilly Automotive price target raised to $535 from $525 at Wells Fargo
03/17/21 Wells Fargo
Advance Auto Parts price target raised to $185 from $165 at Wells Fargo
ORLY O'Reilly Automotive
$530.48 /

+8.3 (+1.59%)

ORLY O'Reilly Automotive
$530.48 /

+8.3 (+1.59%)

Periodicals
ChargePoint, Volta among EV charging stocks at fire-sale prices, Barron's says » 10:59
04/17/21
04/17
10:59
04/17/21
10:59
CHPT

ChargePoint

$22.27 /

-1.61 (-6.74%)

, CLII

Climate Change Crisis Real Impact I

$11.04 /

-0.585 (-5.03%)

, SNPR

Tortoise Acquisition Corp. II

$10.01 /

-0.07 (-0.69%)

, TPGY

TPG Pace Beneficial Finance

$14.41 /

-1.28 (-8.16%)

EV charging stocks are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TPGY TPG Pace Beneficial Finance
$14.41 /

-1.28 (-8.16%)

SNPR Tortoise Acquisition Corp. II
$10.01 /

-0.07 (-0.69%)

CLII Climate Change Crisis Real Impact I
$11.04 /

-0.585 (-5.03%)

CHPT ChargePoint
$22.27 /

-1.61 (-6.74%)

CHPT ChargePoint
$22.27 /

-1.61 (-6.74%)

04/16/21
ChargePoint initiated with Buy, $29 target at R.F. Lafferty
03/25/21 Citi
ChargePoint initiated with a Neutral at Citi
03/08/21 Cowen
ChargePoint initiated with an Outperform at Cowen
03/08/21 Cowen
ChargePoint initiated with an Outperform at Cowen
CLII Climate Change Crisis Real Impact I
$11.04 /

-0.585 (-5.03%)

SNPR Tortoise Acquisition Corp. II
$10.01 /

-0.07 (-0.69%)

TPGY TPG Pace Beneficial Finance
$14.41 /

-1.28 (-8.16%)

CHPT ChargePoint
$22.27 /

-1.61 (-6.74%)

TPGY TPG Pace Beneficial Finance
$14.41 /

-1.28 (-8.16%)

SNPR Tortoise Acquisition Corp. II
$10.01 /

-0.07 (-0.69%)

CLII Climate Change Crisis Real Impact I
$11.04 /

-0.585 (-5.03%)

CHPT ChargePoint
$22.27 /

-1.61 (-6.74%)

TPGY TPG Pace Beneficial Finance
$14.41 /

-1.28 (-8.16%)

SNPR Tortoise Acquisition Corp. II
$10.01 /

-0.07 (-0.69%)

CLII Climate Change Crisis Real Impact I
$11.04 /

-0.585 (-5.03%)

CHPT ChargePoint
$22.27 /

-1.61 (-6.74%)

Periodicals
PetIQ 'a smart way' to play pet care boom, Barron's says » 10:48
04/17/21
04/17
10:48
04/17/21
10:48
PETQ

PetIQ

$37.06 /

+0.43 (+1.17%)

, CHWY

Chewy

$84.15 /

-2.435 (-2.81%)

, FRPT

Freshpet

$172.13 /

+1.63 (+0.96%)

, IDXX

Idexx Laboratories

$535.29 /

+7.12 (+1.35%)

, ZTS

Zoetis

$167.59 /

+2.08 (+1.26%)

Pet-supply sales are…

Pet-supply sales are going strong as pet owners buy everything from kibble infused with quinoa and avocado to hip-and-joint supplements to prevent arthritis, Daren Fonda writes in this week's edition of Barron's. PetIQ (PETQ) is flourishing in this climate, and its stock looks like one of the few bargains in the sector, the author notes. The company manufactures and distributes pet-health products and operates veterinary clinics around the country. At recent prices around $36, the stock trades for 19 times estimated 2022 earnings. That's far cheaper than larger companies in the booming pet sector, including Chewy (CHWY), FreshPet (FRPT), Idexx Laboratories (IDXX), and Zoetis (ZTS), the publication adds. Reference Link

ShowHide Related Items >><<
ZTS Zoetis
$167.59 /

+2.08 (+1.26%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

10/15/20 Jefferies
PetIQ assumed with a Buy at Jefferies
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
07/01/20 Raymond James
PetIQ price target raised to $41 from $35 at Raymond James
06/25/20 Guggenheim
PetIQ price target raised to $44 from $33.50 at Guggenheim
CHWY Chewy
$84.15 /

-2.435 (-2.81%)

04/05/21 Evercore ISI
Chewy assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Chewy initiated with a Peer Perform at Wolfe Research
03/31/21 Wedbush
Chewy price target raised to $100 from $90 at Wedbush
03/31/21 Jefferies
Chewy price target raised to $105 from $100 at Jefferies
FRPT Freshpet
$172.13 /

+1.63 (+0.96%)

03/11/21 DA Davidson
Freshpet price target raised to $217 from $194 at DA Davidson
02/25/21 Truist
Freshpet price target raised to $150 from $140 at Truist
02/25/21 Citi
Freshpet price target raised to $123 from $100 at Citi
02/24/21 DA Davidson
Freshpet price target raised to $194 from $172 at DA Davidson
IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
ZTS Zoetis
$167.59 /

+2.08 (+1.26%)

03/09/21 Stifel
Zoetis 'oversold,' among 'best long-term ideas,' says Stifel
03/08/21 Raymond James
Zoetis upgraded to Outperform from Market Perform at Raymond James
03/08/21 Raymond James
Zoetis upgraded to Outperform from Market Perform at Raymond James
03/08/21 BofA
Zoetis upgraded to Buy from Neutral at BofA
ZTS Zoetis
$167.59 /

+2.08 (+1.26%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

FRPT Freshpet
$172.13 /

+1.63 (+0.96%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

  • 13
    Apr
  • 20
    Apr
  • 12
    Mar
  • 24
    Feb
  • 17
    Sep
CHWY Chewy
$84.15 /

-2.435 (-2.81%)

FRPT Freshpet
$172.13 /

+1.63 (+0.96%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

PETQ PetIQ
$37.06 /

+0.43 (+1.17%)

IDXX Idexx Laboratories
$535.29 /

+7.12 (+1.35%)

CHWY Chewy
$84.15 /

-2.435 (-2.81%)

Periodicals
Streaming could power future profits for Disney, Barron's says » 10:39
04/17/21
04/17
10:39
04/17/21
10:39
DIS

Disney

$187.28 /

+1.42 (+0.76%)

Bob Chapek, who ran the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$187.28 /

+1.42 (+0.76%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

04/16/21 Truist
Disney price target raised to $205 from $195 at Truist
04/16/21 UBS
Disney checks show improving backdrop, says UBS
04/08/21 KeyBanc
Netflix, Disney superior retention reinforces scale advantages, says KeyBanc
03/29/21 Loop Capital
ViacomCBS upgraded to Hold at Loop Capital after share price decline
DIS Disney
$187.28 /

+1.42 (+0.76%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

DIS Disney
$187.28 /

+1.42 (+0.76%)

On The Fly
Opening Day: Coinbase soars in market debut » 09:03
04/17/21
04/17
09:03
04/17/21
09:03
RXRX

Recursion Pharmaceuticals

$31.06 /

+0.81 (+2.68%)

, BMEA

Biomea Fusion

$18.48 /

-1.92 (-9.41%)

, AKYA

Akoya Biosciences

$26.92 /

+0.18 (+0.67%)

, APP

AppLovin

$61.01 /

-3.795 (-5.86%)

, AGL

Agilon Health

$30.45 /

-0.43 (-1.39%)

, KRT

Karat Packaging

$18.38 /

-0.52 (-2.75%)

, TSP

TuSimple

$39.99 /

+0.53 (+1.34%)

, EBET

Esports Technologies

$25.35 /

-10.69 (-29.66%)

, COIN

Coinbase

$341.27 /

+15.78 (+4.85%)

, ALKT

Alkami

$42.13 /

-0.13 (-0.31%)

, SQSP

Squarespace

/

+

, SVFD

Save Foods

/

+

, RGCB

Regencell Bioscience

/

+

, SWIM

Latham Group

/

+

, EDR

Endeavor

$41.49 /

+ (+0.00%)

, UBER

Uber

$60.34 /

-0.405 (-0.67%)

, LYFT

Lyft

$63.36 /

-1.07 (-1.66%)

Shares of Coinbase jumped…

ShowHide Related Items >><<
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

RXRX Recursion Pharmaceuticals
$31.06 /

+0.81 (+2.68%)

BMEA Biomea Fusion
$18.48 /

-1.92 (-9.41%)

AKYA Akoya Biosciences
$26.92 /

+0.18 (+0.67%)

APP AppLovin
$61.01 /

-3.795 (-5.86%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

KRT Karat Packaging
$18.38 /

-0.52 (-2.75%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

04/15/21 Loop Capital
Loop Capital starts Coinbase at Buy, sees 'lots of runway before takeoff'
04/15/21 Loop Capital
Coinbase initiated with a Buy at Loop Capital
04/15/21
Fly Intel: Top five analyst initiations
04/15/21 DA Davidson
Coinbase price target raised to $650 from $440 at DA Davidson
ALKT Alkami
$42.13 /

-0.13 (-0.31%)

SQSP Squarespace
/

+

SVFD Save Foods
/

+

RGCB Regencell Bioscience
/

+

SWIM Latham Group
/

+

EDR Endeavor
$41.49 /

+ (+0.00%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

04/12/21 Truist
Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist
04/05/21 Evercore ISI
Uber assumed with an Outperform at Evercore ISI
04/01/21
Fly Intel: Top five analyst initiations
04/01/21 Jefferies
Uber initiated with a Buy at Jefferies
LYFT Lyft
$63.36 /

-1.07 (-1.66%)

04/05/21 Evercore ISI
Lyft assumed with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Lyft assumed with a Peer Perform at Wolfe Research
03/26/21
Fly Intel: Top five analyst initiations
03/26/21 Vertical Research
Lyft initiated with a Buy at Vertical Research
UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

  • 23
    Apr
  • 14
    Apr
  • 15
    Apr
  • 16
    Apr
  • 16
    Apr
  • 16
    Apr
  • 15
    Apr
  • 15
    Apr
  • 15
    Apr
  • 14
    Apr
  • 15
    Apr
  • 08
    Jan
UBER Uber
$60.34 /

-0.405 (-0.67%)

TSP TuSimple
$39.99 /

+0.53 (+1.34%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

SQSP Squarespace
/

+

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

EBET Esports Technologies
$25.35 /

-10.69 (-29.66%)

COIN Coinbase
$341.27 /

+15.78 (+4.85%)

AGL Agilon Health
$30.45 /

-0.43 (-1.39%)

UBER Uber
$60.34 /

-0.405 (-0.67%)

LYFT Lyft
$63.36 /

-1.07 (-1.66%)

Periodicals
Peloton fighting recall of treadmill after child death, Washington Post says » 08:30
04/17/21
04/17
08:30
04/17/21
08:30
PTON

Peloton

$116.17 /

-3.77 (-3.14%)

A month after disclosing…

A month after disclosing that one child died and others were injured in accidents on its treadmills, Peloton Interactive is fighting request by the Consumer Product Safety Commission that it recall the products and has delayed the agency's investigation into potential safety problems, Todd Frankel of Washington Post reports, citing officials familiar with the case. The Consumer Product Safety Commission this week took the unusual step of filing an administrative subpoena to require Peloton to disclose the name of the child who died, the officials told the paper. Peloton and regulators have been negotiating this week over the wording and timing of an agency warning to alert consumers to potential dangers posed by the Peloton Tread+, and a new safety warning from the CPSC is expected to be posted as early as Saturday, the officials said. Reference Link

ShowHide Related Items >><<
PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

04/07/21 KeyBanc
Peloton Bike OTD times improving further, says KeyBanc
04/06/21 Credit Suisse
Peloton initiated with an Outperform at Credit Suisse
04/05/21 Evercore ISI
Peloton assumed at In Line from Outperform at Evercore ISI
03/31/21 Wolfe Research
Peloton initiated with a Peer Perform at Wolfe Research
PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

PTON Peloton
$116.17 /

-3.77 (-3.14%)

Hot Stocks
QuantumScape CEO: We pride ourselves on our transparency » 18:41
04/16/21
04/16
18:41
04/16/21
18:41
QS

QuantumScape

$35.52 /

-0.355 (-0.99%)

In an interview on…

In an interview on CNBC's Mad Money, Jagdeep Singh said QuantumScape has always been transparent about its data and about work that still needs to be done. "We're confident that the numbers we have are groundbreaking," he added. Singh noted that QuantumScape's core people have been with company for ten years and are not simply looking to make fast money. "They're a long-term committed team on a mission," he said. When asked about Scorpion Capital's allegations, he claimed that some of their points are "absurd."

ShowHide Related Items >><<
QS QuantumScape
$35.52 /

-0.355 (-0.99%)

QS QuantumScape
$35.52 /

-0.355 (-0.99%)

03/08/21 Cowen
Cowen bullish on battery technology, starts QuantumScape at Outperform
03/08/21 Cowen
QuantumScape initiated with an Outperform at Cowen
03/04/21 Baird
QuantumScape initiated with a Neutral at Baird
02/11/21 Morgan Stanley
QuantumScape initiated with an Overweight at Morgan Stanley
  • 25
    Mar
QS QuantumScape
$35.52 /

-0.355 (-0.99%)

QS QuantumScape
$35.52 /

-0.355 (-0.99%)

QS QuantumScape
$35.52 /

-0.355 (-0.99%)

Hot Stocks
Metromile CEO: Customers join initially because they save money » 18:24
04/16/21
04/16
18:24
04/16/21
18:24
MILE

Metromile

$7.96 /

-0.385 (-4.62%)

In an interview on…

In an interview on CNBC's Mad Money, Dan Preston said Metromile's customers save 47% on average relative to fixed rate insurance. He added that the company's word of mouth advertising is very strong as clients tend to share their positive experiences with many others. Metromile's customer retention rate is comparably better than most insurers, Preston noted.

ShowHide Related Items >><<
MILE Metromile
$7.96 /

-0.385 (-4.62%)

MILE Metromile
$7.96 /

-0.385 (-4.62%)

04/06/21 Piper Sandler
Metromile initiated with an Overweight at Piper Sandler
MILE Metromile
$7.96 /

-0.385 (-4.62%)

MILE Metromile
$7.96 /

-0.385 (-4.62%)

MILE Metromile
$7.96 /

-0.385 (-4.62%)

Hot Stocks
BlackRock senior managing director Wiedman sells 1,725 common shares » 17:16
04/16/21
04/16
17:16
04/16/21
17:16
BLK

BlackRock

$810.65 /

-8.11 (-0.99%)

In a regulatory filing,…

In a regulatory filing, BlackRock senior managing director Mark Wiedman disclosed the sale of 1,725 common shares of the company on April 16 at a price of $812.5268 per share.

ShowHide Related Items >><<
BLK BlackRock
$810.65 /

-8.11 (-0.99%)

BLK BlackRock
$810.65 /

-8.11 (-0.99%)

04/16/21 Credit Suisse
BlackRock price target raised to $984 from $949 at Credit Suisse
04/16/21 Deutsche Bank
BlackRock price target raised to $912 from $847 at Deutsche Bank
04/16/21 Citi
BlackRock price target raised to $1,000 from $950 at Citi
04/16/21 Barclays
BlackRock price target raised to $925 from $850 at Barclays
BLK BlackRock
$810.65 /

-8.11 (-0.99%)

  • 13
    May
BLK BlackRock
$810.65 /

-8.11 (-0.99%)

BLK BlackRock
$810.65 /

-8.11 (-0.99%)

Syndicate
Sellas Life Sciences files $150M mixed securities shelf  17:11
04/16/21
04/16
17:11
04/16/21
17:11
SLS

Sellas Life Sciences

$7.50 /

-0.38 (-4.82%)

 
ShowHide Related Items >><<
SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
12/21/20 Alliance Global Partners
Alliance Global Partners keeps Buy on Sellas following data from trials
SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

SLS Sellas Life Sciences
$7.50 /

-0.38 (-4.82%)

Hot Stocks
Citadel Advisors reports 5.8% passive stake in AST SpaceMobile » 17:07
04/16/21
04/16
17:07
04/16/21
17:07
ASTS

AST SpaceMobile

$7.84 /

-0.61 (-7.22%)

Citadel Advisors…

Citadel Advisors disclosed a 5.8% stake in AST SpaceMobile, which represents over 3.01M shares. The filing does not allow for activism.

ShowHide Related Items >><<
ASTS AST SpaceMobile
$7.84 /

-0.61 (-7.22%)

ASTS AST SpaceMobile
$7.84 /

-0.61 (-7.22%)

ASTS AST SpaceMobile
$7.84 /

-0.61 (-7.22%)

Hot Stocks
Afya acquires Cliquefarma for R$19M » 17:05
04/16/21
04/16
17:05
04/16/21
17:05
AFYA

Afya

$23.84 /

+0.84 (+3.65%)

Afya announced the…

Afya announced the acquisition of 100% of the total share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in Brazil. Users of Cliquefarma can search for medications or healthcare products and compare prices from over 5,000 pharmacies in Brazil. The traffic generated is monetized through a cost-per-click model, where drugstores pay for each click on their ads. In 2020 Cliquefarma generated traffic of 20M visitors and R$43.2M in gross merchandise volume, the latter representing a 52.9% growth compared to 2019. The aggregate purchase price is R$19M of which 84.2% paid in cash and 15.8% is paid in Afya stocks as the date hereof. An earn-out of R$3M can be paid related to product development. This aggregate purchase price is equivalent to a 4.1x gross revenue multiple for 2021 expected gross revenue.

ShowHide Related Items >><<
AFYA Afya
$23.84 /

+0.84 (+3.65%)

AFYA Afya
$23.84 /

+0.84 (+3.65%)

04/15/21 UBS
UBS upgrades Afya to Buy on 'underappreciated resiliency'
04/15/21 UBS
Afya upgraded to Buy from Neutral at UBS
02/04/21 JPMorgan
Afya upgraded to Overweight from Neutral at JPMorgan
10/19/20 JPMorgan
Afya downgraded to Neutral from Overweight at JPMorgan
AFYA Afya
$23.84 /

+0.84 (+3.65%)

AFYA Afya
$23.84 /

+0.84 (+3.65%)

Hot Stocks
USW proposes continuation of in-person negotiations with Allegheny Technologies » 16:54
04/16/21
04/16
16:54
04/16/21
16:54
ATI

Allegheny Technologies

$22.06 /

-0.1 (-0.45%)

The United Steelworkers…

The United Steelworkers said that the union has proposed returning to negotiations in-person with ATI to resolve the outstanding issues that led about 1,300 workers at nine facilities to strike over unfair labor practices on March 30, 2021. USW International Vice President David McCall, who chairs the union's negotiations with ATI, said that he hopes the overwhelming solidarity shown by the USW membership gives management an opportunity to show workers respect they have earned. "Our progress has been hindered at every step by the company dragging its feet and violating labor law," McCall said. "Now is the time for ATI to commit to resolve the outstanding issues in good faith at the bargaining table."

ShowHide Related Items >><<
ATI Allegheny Technologies
$22.06 /

-0.1 (-0.45%)

ATI Allegheny Technologies
$22.06 /

-0.1 (-0.45%)

03/16/21 Barclays
Allegheny Technologies upgraded to Overweight from Equal Weight at Barclays
01/15/21
Fly Intel: Top five analyst initiations
01/15/21 Seaport Global
Allegheny Technologies initiated with a Buy at Seaport Global
12/07/20 KeyBanc
Allegheny Technologies price target raised to $25 from $15 at KeyBanc
ATI Allegheny Technologies
$22.06 /

-0.1 (-0.45%)

Conference/Events
MGM Resorts to host analyst and investor virtual meeting » 16:54
04/16/21
04/16
16:54
04/16/21
16:54
MGM

MGM Resorts

$40.27 /

+0.59 (+1.49%)

Virtual Analyst &…

Virtual Analyst & Investor Meeting to be held on April 21 at 11 am. Webcast Link

ShowHide Related Items >><<
MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
04/05/21
Fly Intel: Top five analyst upgrades
04/05/21 Morgan Stanley
Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit
MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

MGM MGM Resorts
$40.27 /

+0.59 (+1.49%)

Syndicate
Brookfield files to sell 11.2M Class A limited voting shares  16:52
04/16/21
04/16
16:52
04/16/21
16:52
BAM

Brookfield

$46.09 /

-0.175 (-0.38%)

 
ShowHide Related Items >><<
BAM Brookfield
$46.09 /

-0.175 (-0.38%)

BAM Brookfield
$46.09 /

-0.175 (-0.38%)

04/09/21 Deutsche Bank
Brookfield price target raised to $45 from $43 at Deutsche Bank
04/01/21 Evercore ISI
Brookfield Property downgraded to In Line from Outperform at Evercore ISI
03/31/21
Fly Intel: Top five analyst downgrades
03/31/21 Credit Suisse
Brookfield downgraded to Neutral from Outperform at Credit Suisse
BAM Brookfield
$46.09 /

-0.175 (-0.38%)

BAM Brookfield
$46.09 /

-0.175 (-0.38%)

BAM Brookfield
$46.09 /

-0.175 (-0.38%)

Syndicate
Second Sight files to sell 4.65M shares of common stock for holders » 16:52
04/16/21
04/16
16:52
04/16/21
16:52
EYES

Second Sight

$7.37 /

-0.76 (-9.35%)

The filing for holders…

The filing for holders was released earlier this morning.

ShowHide Related Items >><<
EYES Second Sight
$7.37 /

-0.76 (-9.35%)

  • 01
    May
EYES Second Sight
$7.37 /

-0.76 (-9.35%)

EYES Second Sight
$7.37 /

-0.76 (-9.35%)

EYES Second Sight
$7.37 /

-0.76 (-9.35%)

Syndicate
EyeGate files to sell 3.93M shares of common stock for holders  16:52
04/16/21
04/16
16:52
04/16/21
16:52
EYEG

EyeGate

$4.26 /

+0.06 (+1.43%)

 
ShowHide Related Items >><<
EYEG EyeGate
$4.26 /

+0.06 (+1.43%)

EYEG EyeGate
$4.26 /

+0.06 (+1.43%)

03/31/21 Alliance Global Partners
EyeGate price target lowered to $10.25 from $16.75 at Alliance Global
02/04/21 Alliance Global Partners
EyeGate price target raised to $16.75 from $15.50 at Alliance Global Partners
12/22/20 Alliance Global Partners
EyeGate price target raised to $15.50 from $9.50 at Alliance Global Partners
12/22/20 H.C. Wainwright
EyeGate price target raised to $14 from $10 at H.C. Wainwright
Hot Stocks
FDA revokes emergency use authorization for Eli Lilly's bamlanivimab » 16:46
04/16/21
04/16
16:46
04/16/21
16:46
LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

The U.S. FDA revoked the…

The U.S. FDA revoked the emergency use authorization that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the sustained increase of SARS-CoV-2 viral variants that are resistant to bamlanivimab alone resulting in the increased risk for treatment failure, the FDA has determined that the known and potential benefits of bamlanivimab, when administered alone, no longer outweigh the known and potential risks for its authorized use. Therefore, the agency determined that the criteria for issuance of an authorization are no longer met and has revoked the EUA. Reference Link

ShowHide Related Items >><<
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

Hot Stocks
Kforce CEO sells 50K shares of common stock » 16:45
04/16/21
04/16
16:45
04/16/21
16:45
KFRC

Kforce

$56.62 /

+1.22 (+2.20%)

In a regulatory filing,…

In a regulatory filing, Kforce disclosed that its CEO David Dunkel sold 50K shares of common stock on April 14th in a total transaction size of $2.8M, reducing his stake by about 6%.

ShowHide Related Items >><<
KFRC Kforce
$56.62 /

+1.22 (+2.20%)

KFRC Kforce
$56.62 /

+1.22 (+2.20%)

03/11/21 Truist
Kforce price target raised to $55 from $48 at Truist
01/20/21 Truist
Kforce price target raised to $48 from $37 at Truist
01/04/21 Sidoti
Kforce upgraded to Buy from Neutral at Sidoti
08/11/20 Truist
Kforce price target raised to $35 from $30 at Truist
KFRC Kforce
$56.62 /

+1.22 (+2.20%)

KFRC Kforce
$56.62 /

+1.22 (+2.20%)

Hot Stocks
Oak Street Health CMO sells 109.4K shares of common stock » 16:44
04/16/21
04/16
16:44
04/16/21
16:44
OSH

Oak Street Health

$58.67 /

+0.99 (+1.72%)

In a regulatory filing,…

In a regulatory filing, Oak Street Health disclosed that its Chief Medical Officer Griffin Myers sold 109.4K shares of common stock on April 15th in a total transaction size of $6.28M, reducing his stake by about 2%.

ShowHide Related Items >><<
OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

03/15/21
Fly Intel: Top five analyst initiations
03/15/21 Evercore ISI
Oak Street Health initiated with an Outperform at Evercore ISI
03/10/21 Piper Sandler
Oak Street Health accelerating revenue growth 'not baked in,' says Piper Sandler
02/24/21 Canaccord
Canaccord starts Oak Street Health at Buy with $67 price target
OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

  • 11
    Feb
  • 03
    Dec
  • 06
    Aug
OSH Oak Street Health
$58.67 /

+0.99 (+1.72%)

Hot Stocks
Icahn cuts Tenneco stake to 13.35% from 14.03% » 16:44
04/16/21
04/16
16:44
04/16/21
16:44
TEN

Tenneco

$10.81 /

+0.07 (+0.65%)

In a regulatory filing,…

In a regulatory filing, Carl Icahn disclosed a 13.35% stake in Tenneco, representing 10,946,841 shares. The move decreases Icahn's stake from 14.03%. The filing allows for activism.

ShowHide Related Items >><<
TEN Tenneco
$10.81 /

+0.07 (+0.65%)

TEN Tenneco
$10.81 /

+0.07 (+0.65%)

04/01/21 Jefferies
Tenneco initiated with a Buy at Jefferies
03/25/21 Wells Fargo
Tenneco initiated with an Overweight at Wells Fargo
02/25/21 Deutsche Bank
Tenneco price target raised to $15 from $13 at Deutsche Bank
01/20/21 Deutsche Bank
Tenneco price target raised to $13 from $11 at Deutsche Bank
TEN Tenneco
$10.81 /

+0.07 (+0.65%)

TEN Tenneco
$10.81 /

+0.07 (+0.65%)

TEN Tenneco
$10.81 /

+0.07 (+0.65%)

Hot Stocks
PPD CEO sells 100K shares of common stock » 16:43
04/16/21
04/16
16:43
04/16/21
16:43
PPD

PPD

$46.30 /

+0.49 (+1.07%)

In a regulatory filing,…

In a regulatory filing, PPD disclosed that its CEO David Simmons sold 100K shares of common stock on April 14th in a total transaction size of $4.2M, reducing his stake by about 7%.

ShowHide Related Items >><<
PPD PPD
$46.30 /

+0.49 (+1.07%)

PPD PPD
$46.30 /

+0.49 (+1.07%)

04/16/21 Deutsche Bank
PPD downgraded to Hold from Buy at Deutsche Bank
04/16/21 William Blair
PPD downgraded to Market Perform from Outperform at William Blair
04/16/21 Evercore ISI
Thermo Fisher price target raised to $540 from $525 at Evercore ISI
04/16/21 Evercore ISI
PPD downgraded to In Line from Outperform at Evercore ISI
PPD PPD
$46.30 /

+0.49 (+1.07%)

  • 17
    Sep
PPD PPD
$46.30 /

+0.49 (+1.07%)

PPD PPD
$46.30 /

+0.49 (+1.07%)

Conference/Events
HP Enterprise participates in a conference call with Wells Fargo » 16:38
04/16/21
04/16
16:38
04/16/21
16:38
HPE

HP Enterprise

$15.94 /

+0.08 (+0.50%)

Conference call with…

Conference call with President & CEO Neri will be held on April 21 at 1 pm hosted by Wells Fargo. Webcast Link

ShowHide Related Items >><<
HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

04/08/21 Morgan Stanley
HP Enterprise price target raised to $17 from $15.50 at Morgan Stanley
03/26/21 JPMorgan
HP Enterprise price target raised to $18 from $17 at JPMorgan
03/10/21
Fly Intel: Top five analyst upgrades
03/10/21 Daiwa
HP Enterprise upgraded to Outperform from Neutral at Daiwa
HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

HPE HP Enterprise
$15.94 /

+0.08 (+0.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.